Nuvama Wealth Management · risk themes across the available quarters.
Bear-case history
Gain Street regulatory suspension may cause ~Rs 15-20 crore PAT impact in FY26 if zero revenue scenario persists. Management expects recovery by Q3 if regulatory engagement concludes favorably.
Analyst raised concerns about IE revenue concentration and regulatory risks affecting hedge fund/HFT clients. Management provided scenario analysis but acknowledged sensitivity to market volume recovery timing.
Management explicitly stated that further rate cuts of 30-50bps could compress asset services yield from 2.1% to 2.0%, creating revenue headwind on fee-paying AUC.
Management flagged external macro risks from US tariff uncertainty causing FIIs to shift flows to Japan, Korea, and Indonesia. Could delay recovery in capital markets volumes beyond Q2-Q3.
Post-SEBI order adjustment period lasted 30-40 days with activity now recovered. However, ongoing regulatory developments around weekly options and potential new rules create residual uncertainty on sustained volume recovery.
Supreme Court has formally admitted the case after two years of procedural delays. Management remains confident of favorable outcome but acknowledges resolution may take several years given court timelines.
Q3 revenue of Rs 755 crore was 2% below Q2's Rs 772 crore due to lumpy transactional revenue in private (Rs 100 crore to Rs 65 crore) and ECM billing deferral to Q4. This creates visibility challenges for quarterly forecasting.
PE-backed platforms aggressively building teams, expanding competition beyond UHNW to HNI/affluent segments. Firms requiring both placement/distribution capability and balance sheet availability to attract quality RMs.